Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas - Test2 - elhamkhani - TriplyDB

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

http://www.wikidata.org/entity/Q34067016

about

P1343

A Complex Interplay between Wnt/β-Catenin Signalling and the Cell Cycle in the Adult Liver Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer Regulation of the Wnt signaling pathway by disabled-2 (Dab2)Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1 WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1 WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells The links between axin and carcinogenesis Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice Identification of Wnt responsive genes using a murine mammary epithelial cell line model system Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Hepatocellular carcinoma and hepatitis B surface protein Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?Development of anticancer agents targeting the Wnt/β-catenin signaling Mouse models of liver cancer: Progress and recommendations Targeted therapy for hepatocellular carcinoma: novel agents on the horizon Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies Molecular pathogenesis of hepatic adenomas and its implications for surgical management A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis Understanding the role of PIN1 in hepatocellular carcinoma Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer

P2860

Q54896848-49942BA0-51DC-4FA6-BB15-F9F7BEE2AA4D

P1343

Q21284963-4C58B14E-024D-443B-9E0C-DE27A825E2E8 Q22010178-DA980085-C5A3-4B8B-827D-1A93C6BE3183 Q22011203-D53F02E7-B83C-41CB-AA5A-6FB807C02DCD Q22254145-C89BA279-B703-4DB7-958B-60B710249FE8 Q24292953-1B931369-DDE5-40ED-A0DF-B04DA8F2CB84 Q24297486-3DECABC5-01EE-47C4-8301-7626A6C46A26 Q24304061-59C3C120-1A63-4FAC-99F5-40E5D0CF0C02 Q24305113-4CD44E51-D02D-43C2-B567-16E1156D3652 Q24318355-31144C17-8790-47E1-8751-F1FC578796E0 Q24319786-751CAFBE-42DE-4C01-B1C0-0542F57D80FC Q24320028-67BB95C7-3047-4CB2-984C-546C6D26D2A9 Q24338737-EFDC0159-F193-47F6-9AD8-19B4B18ACEF4 Q24550874-98B7A34D-D4F9-4D88-8D42-40CD757C77E2 Q24555051-83ACD599-7BD7-4D42-B5DD-FD43012997DD Q24600979-9F797824-B62D-4B31-9BD6-567A04F8AF69 Q24608963-3E59C676-9E31-4AE5-ABBF-E4C7B7D8E550 Q24645174-556D3F48-C12C-432F-A0AE-97A62933BB46 Q24647244-A860323E-B491-4ADA-921A-D6D755B159C2 Q24647547-74FB1A48-5670-4D42-9F8E-6A397AE512B0 Q24669950-9C036A59-BA1D-44DD-8497-B42435ECFC51 Q24672469-96BDE29F-3D79-468C-9DE3-BF48D1D4AF16 Q24680214-4687F161-11FB-4FFA-9DD5-C128204159E4 Q24685118-EFCDE61A-8E2C-4120-8110-A6040A2FF1B0 Q24793754-8488EA0F-012D-49B0-AD02-B94581A8D699 Q26738293-4055D3DF-DE4F-4376-8B8A-4D7DE97EB14F Q26766123-D447E220-2900-4D03-921B-69EA70035CB5 Q26766689-4F0FEF1C-4248-43FB-83D4-E5D1987A5344 Q26781898-8AC3F7AE-0AC2-439D-92ED-54076922540F Q26799788-FED81C6F-810F-457F-A393-CF7738A2D834 Q27002288-28A8B680-B920-4584-AAC0-E4F7EA3E01D3 Q27008537-54ECCBB5-F8DE-471A-9036-543A56C424B9 Q27027370-DACCC33D-C216-4111-AA63-30C16DE8AC3E Q27301472-3731F986-23DC-47F2-8DA2-5F40B3E9CACF Q27469443-FB72B6E3-80F2-4E75-B271-3B61FFE94205 Q27478395-87FA45AC-97D0-4037-BD35-3978BB858210 Q27478444-F140DD85-D1B2-4877-B87A-26ABA8A754D1 Q27489394-3713A2F7-83B8-4723-B931-9A656A9A71C2 Q28073477-8B0B7713-36FC-49DB-8649-085C2ECACA39 Q28084948-B6C7C8C4-2A7F-402E-960F-624349480898 Q28085644-97A1067B-50EF-4935-8911-8B386B7F79C9

P2860

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

http://www.wikidata.org/entity/Q34067016

description

1998 nî lūn-bûn

@nan

1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

name

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@ast

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@en

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@nl

type

label

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@ast

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@en

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@nl

prefLabel

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@ast

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@en

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@nl

P1433

Q34067016-408F7119-9EB2-4D7C-8320-8758783D4357

P1476

Q34067016-B8A44CD4-D7DA-4A24-8C87-41DC8DD8A82B

P2093

Q34067016-11C9D6BC-0D73-4784-B2B6-C6BDB393B72C

Q34067016-3BF342BD-0CEC-4448-82E5-B63A98CD57D1

Q34067016-4170490B-9FF6-41D2-AD92-103CD39C74D9

Q34067016-631A1134-D3FC-4AD7-B1F9-6E0DD44BAF20

Q34067016-72ACDBDA-54FB-4FCC-91C8-840F236044E5

Q34067016-82062EE3-13E4-4368-A4B5-BB6399C36067

Q34067016-95C95157-5447-444C-A494-FF7DE6CC20ED

Q34067016-9E603D6E-9E73-4B29-A24D-6F49D3806BE9

Q34067016-C52AE8CF-1A34-4649-9A50-37F9844225B7

Q34067016-DD96EF68-B1A9-4628-B426-A932B2B9F340

P2860

Q34067016-13DB48F2-1930-4CAE-BB80-C36F77779BD6

Q34067016-1598BFD6-E741-4F8C-AF62-34BE8E8C6F7B

Q34067016-1684F410-A70D-4345-BA07-570B191EB00C

Q34067016-195B7FB1-DC10-4A22-A5A4-7AFFFB3DCF1E

Q34067016-22131C62-E1AA-4B17-B167-6B77C0EAD308

Q34067016-26D4C835-F890-48B8-90A6-46045DBDD43A

Q34067016-2F198D7E-8760-4284-99CD-0E59B6F4668E

Q34067016-3C4CC3CF-5647-4FF6-9AA1-A8E3306DC982

Q34067016-3F58D580-C0B2-48CA-B56E-9EB46D0CD82B

Q34067016-41FAEDA2-C2D0-4E46-828B-854E8AD98DDB

P304

Q34067016-0B7B3570-9B29-4964-AD4A-6D6C70EC72BB

P31

Q34067016-B7C5E156-B8E9-4594-87C5-5F89F6325EFD

P356

Q34067016-9F0354A5-5A3D-4652-8F69-53F957C57AE6

P407

Q34067016-AED5CAFC-C1BE-4550-8757-DD503CF214CB

P433

Q34067016-2097E2D4-08B8-48E5-AA47-F2B85796BAEE

P478

Q34067016-D4DB0B75-DEBA-4731-B0B5-0C6466049DC0

P577

Q34067016-36AF3273-1CD8-42B7-8A0B-15854F8174D0

P5875

Q34067016-FFBD7BF9-894C-4FE6-A126-DFDCE843EB29

P698

Q34067016-F12F8045-74B8-48C0-8DB3-C7C722480FCB

P932

Q34067016-AAB91C3B-D13A-4638-9489-2D16D7EF2FE0

P356

PNAS.95.15.8847

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Somatic mutations of the beta- ...... uman hepatocellular carcinomas

@en

P2093

Beldjord C

http://www.w3.org/2001/XMLSchema#string

Billuart P

http://www.w3.org/2001/XMLSchema#string

Buendia MA

http://www.w3.org/2001/XMLSchema#string

Chelly J

http://www.w3.org/2001/XMLSchema#string

Fabre M

http://www.w3.org/2001/XMLSchema#string

Kahn A

http://www.w3.org/2001/XMLSchema#string

Perret C

http://www.w3.org/2001/XMLSchema#string

Renard CA

http://www.w3.org/2001/XMLSchema#string

Romagnolo B

http://www.w3.org/2001/XMLSchema#string

Soubrane O

http://www.w3.org/2001/XMLSchema#string

P2860

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Lessons from hereditary colorectal cancer

A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

Functional interaction of beta-catenin with the transcription factor LEF-1

XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos

High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat

beta-catenin is a target for the ubiquitin-proteasome pathway

The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3

P304

8847-8851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.15.8847

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235617301

http://www.w3.org/2001/XMLSchema#string

P698

9671767

http://www.w3.org/2001/XMLSchema#string

P932

21165

http://www.w3.org/2001/XMLSchema#string